Tag: GCP compliance

Designing Clinical Quality KPIs, KRIs and QTLs That Matter to Regulators

November 16, 2025November 15, 2025 digi

Designing Clinical Quality KPIs, KRIs and QTLs That Matter to Regulators Designing Clinical Quality KPIs, KRIs and QTLs That Matter to Regulators In the ever-evolving landscape of clinical research, the significance of data management cannot be overstated. Regulatory agencies, including the FDA, EMA, and MHRA, underscore the importance of pragmatic metrics in ensuring the integrity…

Metrics & Quality KPIs (KRIs/QTLs)

Decentralized and Hybrid Models for Screening and Enrollment

November 16, 2025November 15, 2025 digi

Decentralized and Hybrid Models for Screening and Enrollment Decentralized and Hybrid Models for Screening and Enrollment The clinical research landscape is continuously evolving, particularly with the advent of decentralized and hybrid clinical trial models. The incorporation of these innovative strategies has the potential to significantly optimize subject screening, enrollment, and retention. In this comprehensive guide,…

Subject Screening, Enrollment & Retention

Inspection Lessons on Poor Documentation of Site Communications

November 16, 2025November 15, 2025 digi

Inspection Lessons on Poor Documentation of Site Communications Inspection Lessons on Poor Documentation of Site Communications Introduction to Clinical Trial Communications The effective management of site communications is a critical component in the landscape of clinical trials. As clinical research professionals, understanding the nuances of communication can have a direct impact on the success of…

Site Communications & Issue Escalation

Using Communication Metrics to Improve Site Relationships Over Time

November 16, 2025 digi

Using Communication Metrics to Improve Site Relationships Over Time Effective communication in clinical trial site management is paramount to ensure not only the success of the trial but also to foster positive relationships with participating sites. This tutorial will guide you through the step-by-step process of employing communication metrics to enhance these relationships over time,…

Site Communications & Issue Escalation

GCP Considerations for AI-Supported Trial Tools and Algorithms

November 16, 2025November 15, 2025 digi

GCP Considerations for AI-Supported Trial Tools and Algorithms GCP Considerations for AI-Supported Trial Tools and Algorithms The integration of artificial intelligence (AI) into clinical trials is rapidly changing the landscape of clinical research. As AI-supported tools and algorithms become more prevalent, especially in decentralized clinical trial settings, it’s crucial for clinical operations, regulatory affairs, and…

GCP in Digital/Decentralized Settings

Metrics for CAPA Lifecycle Health: Overdue, Reopened and Ineffective CAPAs

November 16, 2025November 15, 2025 digi

Metrics for CAPA Lifecycle Health: Overdue, Reopened and Ineffective CAPAs Metrics for CAPA Lifecycle Health: Overdue, Reopened and Ineffective CAPAs Corrective and preventive actions (CAPA) are essential components of quality management in clinical trials. Efficiently managing CAPA lifecycle health is crucial for ensuring compliance with regulatory requirements and improving overall clinical trial efficacy. This tutorial…

Corrective & Preventive Action (CAPA) Lifecycle

Aligning Medical, Clinical Operations and Safety Messaging to Sites

November 16, 2025November 15, 2025 digi

Aligning Medical, Clinical Operations and Safety Messaging to Sites Aligning Medical, Clinical Operations and Safety Messaging to Sites In the context of clinical trials, effective communication between various stakeholders—the clinical operations team, medical affairs, and site personnel—is paramount. The collaboration and information-sharing can greatly affect both the quality of the data collected and the overall…

Site Communications & Issue Escalation

Communication During Database Lock, Close-Out and Results Disclosure

November 16, 2025November 15, 2025 digi

Communication During Database Lock, Close-Out and Results Disclosure Communication During Database Lock, Close-Out and Results Disclosure In the realm of clinical trials, the phases surrounding database lock, close-out, and the disclosure of results are critical. They require targeted communication strategies from clinical operations, regulatory affairs, and medical affairs professionals, particularly in prominent regions such as…

Site Communications & Issue Escalation

Hybrid Site and Remote Models: GCP Risks and Mitigation Strategies

November 16, 2025November 15, 2025 digi

Hybrid Site and Remote Models: GCP Risks and Mitigation Strategies Hybrid Site and Remote Models: GCP Risks and Mitigation Strategies As clinical trials evolve to accommodate advancements in technology and patient accessibility, hybrid site and remote models have become increasingly prominent. This article is a step-by-step guide focused on Good Clinical Practice (GCP) compliance in…

GCP in Digital/Decentralized Settings

Inspection Readiness for Digital and Decentralized Clinical Programs

November 16, 2025November 15, 2025 digi

Inspection Readiness for Digital and Decentralized Clinical Programs Inspection Readiness for Digital and Decentralized Clinical Programs In the evolving landscape of clinical trials, digital and decentralized methodologies are gaining prominence. As clinical operations, regulatory affairs, and medical affairs professionals, ensuring inspection readiness for these innovative approaches is essential. This comprehensive guide outlines the steps necessary…

GCP in Digital/Decentralized Settings